12/23
08:37 am
bngo
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis [Yahoo! Finance]
Medium
Report
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis [Yahoo! Finance]
12/23
08:30 am
bngo
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis
Low
Report
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis
12/19
08:07 am
bngo
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal [Yahoo! Finance]
Low
Report
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal [Yahoo! Finance]
12/19
08:00 am
bngo
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
Medium
Report
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
12/10
08:14 am
bngo
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy [Yahoo! Finance]
Medium
Report
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy [Yahoo! Finance]
12/10
08:00 am
bngo
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy
Medium
Report
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy
11/15
08:16 am
bngo
Bionano Genomics, Inc. (NASDAQ: BNGO) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.
Medium
Report
Bionano Genomics, Inc. (NASDAQ: BNGO) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.
11/14
02:31 am
bngo
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... [Yahoo! Finance]
Low
Report
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... [Yahoo! Finance]
11/13
08:54 pm
bngo
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/13
04:12 pm
bngo
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress [Yahoo! Finance]
Medium
Report
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress [Yahoo! Finance]
11/13
04:01 pm
bngo
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress
Medium
Report
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress
11/7
04:01 pm
bngo
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
Medium
Report
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
11/4
04:22 am
bngo
Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry [Yahoo! Finance]
Low
Report
Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry [Yahoo! Finance]
10/31
04:30 pm
bngo
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Medium
Report
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
10/31
08:10 am
bngo
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024
Low
Report
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024
10/31
08:00 am
bngo
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Medium
Report
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
10/24
08:00 am
bngo
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
Low
Report
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
10/10
08:00 am
bngo
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
High
Report
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
10/3
08:00 am
bngo
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024
Low
Report
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024